Author: Rachel Paul

Rachel Paul is a Senior Medical Content Specialist. She has a Masters Degree in Pharmacy from Osmania University. She always has a keen interest in medical and health sciences. She expertly communicates and crafts latest informative and engaging medical and healthcare narratives with precision and clarity. She is proficient in researching, writing, editing, and proofreading medical content and blogs.

alzheimers diagnosis
Blood Biomarkers: Revolutionizing Alzheimer’s Diagnosis

In a recent analysis published in the journal Nature Reviews Neurology, a group of writers.

Donezepil
Combining Donepezil & Memantine Extends Lives in Alzheimer’s

Alzheimer’s disease is the most prevalent neurological illness, affecting about 50 million individuals worldwide. Alzheimer’s.

malaria detection
Efficient Deep Learning for Malaria Detection with AI

In a recent study published in Scientific Reports, a team of researchers recommended utilizing an.

pediatric brain tumor
MRI & AI reduce Pediatric Brain Tumor Diagnosis Time

Children with the most common malignant form of brain cancer may see shorter diagnostic wait.

Lung Cancer Screening
Real-World Lung Cancer Screening Found to Prolong Lives

Among US veterans diagnosed with lung cancer through the Veterans Health Administration health care system,.

ADHD
Younger Kids More Often Diagnosed with ADHD

A new study done by scientists at the University of Nottingham discovered that teachers may.

dementia
Dementia Prediction Method Up to 9 Years Early

Researchers at Queen Mary University of London have created a new method for detecting dementia.

long COVID
IgG from Long COVID Patients Induces Symptoms in Mice

In a recent study published on the bioRxiv preprint* server, researchers demonstrated that transfer of.

dementia risk
Can Dementia Risk be lowered by Mobile Health Coaching

Recent findings published in The Lancet Healthy Longevity highlight the potential of a coach-supported mobile.

biomarker for Long covid
IFN-γ as a potential biomarker for Long COVID

A University of Cambridge-led study identifies the protein interferon gamma (IFN-γ) as a potential biomarker for Long COVID fatigue.